Results 311 to 320 of about 178,774 (332)

Bevacizumab

Reactions Weekly, 2016
openaire   +2 more sources

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

Nature Medicine, 2018
David F Mcdermott, Mahrukh A Huseni, Michael B Atkins   +2 more
exaly  

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine, 2020
, Shukui Qin, Masafumi Ikeda
exaly  

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Nature Reviews Drug Discovery, 2004
Napoleone Ferrara, Hans-Peter Gerber
exaly  

Bevacizumab

Reactions Weekly, 2014
openaire   +1 more source

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Nature Medicine, 2004
Dan G Duda, Lance L Munn, Daniel C Chung
exaly  

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

Cancer Treatment Reviews, 2020
Robert L Coleman
exaly  

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Journal of Clinical Oncology, 2008
Leonard B Saltz, Stephen Clarke, Fernando Rivera   +2 more
exaly  

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Lancet, The, 2019
Brian I Rini, Thomas Powles, Michael B Atkins   +2 more
exaly